# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yis...
CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with ...
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) ("Clearmind" or the "Company"), a clinical- stage biot...